PAMS
TWST icon

Pictet Asset Management (Switzerland)’s Twist Bioscience TWST Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-20,912
Closed -$1.03M – 1689
2022
Q1 		$1.03M Sell
20,912
-3,684
-15% -$204K ﹤0.01% 1053
2021
Q4 		$1.9M Buy
24,596
+3,062
+14% +$314K ﹤0.01% 1000
2021
Q3 		$2.3M Buy
+21,534
New +$2.47M ﹤0.01% 982

Other funds holding TWST

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Pictet Asset Management (Switzerland)'s TWST Position: Q2 2022 in Review

Pictet Asset Management (Switzerland) sold out of Twist Bioscience (TWST) in Q2 2022, closing a stake of 20,912 shares — an estimated $1.03M sold.

Pictet Asset Management (Switzerland) first reported a position in TWST in Q3 2021 and held it in 3 quarters. The position peaked at $2.3M in Q3 2021. 205 funds tracked by Wall St. Rank hold TWST as of Q2 2022.

  • Pictet Asset Management (Switzerland) reported no remaining Twist Bioscience position as of Q2 2022 after selling out during the quarter.
  • Pictet Asset Management (Switzerland) sold 20,912 Twist Bioscience shares in Q2 2022, an estimated $1.03M.
  • Pictet Asset Management (Switzerland) first reported a position in Twist Bioscience in Q3 2021 and held it in 3 quarters.
  • Pictet Asset Management (Switzerland)'s Twist Bioscience position peaked at $2.3M in Q3 2021.
  • 205 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2022.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2022, filed 9 Aug 2022.